Active Ingredient: PHENTERMINE HYDROCHLORIDE
Proprietary Name: WILPO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N012737
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SANDOZ CONSUMER HEALTH CARE GROUP DIV SANDOZ PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information